Table 6.6b

Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006

Recipients with Pancreas Transplant Alone (PTA) Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
Tac CyA+ MMF Tac+ MMF Tac+ Aza Siro+ MMF CyA+ Siro Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 231 9 355 3 3 4 79 118 802
% of All Regimens 28.8% 1.1% 44.3% 0.4% 0.4% 0.5% 9.9% 14.7% 100.0%
Induction Drug 0.0% 0.0% 1.7% 0.0% 0.0% 0.0% 0.0% 0.8% 0.9%
Atgam/NRATG/NRATS
OKT3 5.6% 0.0% 0.6% 0.0% 0.0% 0.0% 1.3% 2.5% 2.4%
Thymoglobulin 22.5% 77.8% 63.7% 66.7% 66.7% 75.0% 34.2% 92.4% 53.4%
Zenapax 15.2% 22.2% 13.5% 33.3% 0.0% 0.0% 15.2% 11.9% 14.0%
Simulect 0.9% 11.1% 3.7% 0.0% 0.0% 0.0% 1.3% 6.8% 3.1%
Campath 28.1% 22.2% 13.2% 33.3% 33.3% 0.0% 41.8% 68.6% 28.7%
No Induction Drugs Recorded 32.9% 11.1% 17.7% 0.0% 33.3% 25.0% 24.1% 8.5% 21.3%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.